Formulir Kontak

Nama

Email *

Pesan *

Cari Blog Ini

Cxm Investors Have Opportunity To Lead Sprinklr Inc Securities Fraud Lawsuit With The Schall Law Firm

WEB DXCM Investors Have Opportunity to Join DexCom Inc Securities Fraud Investigation with the Schall Law Firm

Schall Law Firm Represents DexCom Inc Investors in Securities Fraud Class Action Lawsuit

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DexCom Inc. ("DexCom" or "the Company") (NASDAQ: DXCM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between February 25, 2022 and July 26, 2023, inclusive (the "Class Period"), are encouraged to contact the firm before the November 7, 2023 lead plaintiff motion deadline.

If you are a shareholder who suffered a loss, click here to participate.

We Investigate DexCom Inc and Violation of Securities Laws

The investigation focuses on whether the Company issued materially false and/or misleading statements and/or failed to disclose material adverse facts about DexCom's business, operations, and prospects. Specifically, the Company issued a series of positive statements about the Company's "G7" continuous glucose monitoring ("CGM") system, including its accuracy, reliability, and user-friendliness.

However, as the market learned on July 27, 2023, DexCom had received numerous complaints about the G7 CGM system. These complaints related to, among other things, the system's inaccurate readings, connectivity issues, and skin irritation. As a result of these complaints, DexCom was forced to issue a series of recalls for the G7 CGM system.

Based on these facts, the plaintiff alleges that the Company's positive statements about the G7 CGM system were materially false and/or misleading and/or failed to disclose material adverse facts about DexCom's business, operations, and prospects. The plaintiff also alleges that the Company failed to disclose the complaints it had received about the G7 CGM system.

Join the DexCom Inc Securities Fraud Class Action Lawsuit

If you are a shareholder who suffered a loss, click here to participate.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

Shareholders have the right to recover for losses incurred as a result of corporate fraud or misconduct. If you believe that your investment has been affected by corporate fraud or misconduct, contact the Schall Law Firm today.

CONTACT:

The Schall Law Firm Mark L. Belzberg, Esq. 1880 Century Park East, Suite 404 Los Angeles, CA 90067 310-301-3335 info@schallfirm.com www.schallfirm.com


Komentar